Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,479

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis

Birnie, David H., Sauer, William H., Bogun, Frank, Cooper, Joshua M., Culver, Daniel A., Duvernoy, Claire S., Judson, Marc A., Kron, Jordana, Mehta, Davendra, Cosedis Nielsen, Jens, Patel, Amit R., Ohe, Tohru, Raatikainen, Pekka, Soejima, Kyoko·2014·Heart Rhythm
DOI 10.1016/j.hrthm.2014.03.043
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hrthm.2014.03.043

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 94

  1. McGrath, 2001, Sarcoidosis: genes and microbes—soil or seed?, Sarcoidosis Vasc Diffuse Lung Dis, 18, 149
  2. 1999, Am J Respir Crit Care Med, 160, 736, 10.1164/ajrccm.160.2.ats4-99 · DOI · Paper page
  3. Morimoto, 2008, Epidemiology of sarcoidosis in Japan, Eur Respir J, 31, 372, 10.1183/09031936.00075307 · DOI · Paper page
  4. Hillerdal, 1984, Sarcoidosis: epidemiology and prognosis. A 15-year European study, Am Rev Respir Dis, 130, 29
  5. Valeyre, 2013, Sarcoidosis, Lancet
  6. Newman, 1997, Sarcoidosis, N Engl J Med, 336, 1224, 10.1056/NEJM199704243361706 · DOI · Paper page
  7. Grutters, 2006, Corticosteroid treatment in sarcoidosis, Eur Respir J, 28, 627, 10.1183/09031936.06.00105805 · DOI · Paper page
  8. Israel, 1995, Outcome of the treatment for sarcoidosis, Am J Respir Crit Care Med, 151, 920, 10.1164/ajrccm/151.3_Pt_1.920a · doi:10.1164/ajrccm/151.3_pt_1.920a
  9. Izumi, 1988, Sarcoidosis in Kyoto (1963-1986), Sarcoidosis, 5, 142
  10. Paramothayan, 2005, Corticosteroids for pulmonary sarcoidosis, Cochrane Database Syst Rev, 10.1002/14651858.CD001114.pub2 · DOI
  11. Ayyala, 2008, Cardiac sarcoidosis, Clin Chest Med, 29, 493, 10.1016/j.ccm.2008.03.005 · DOI
  12. Dubrey, 2010, Diagnosis and management of cardiac sarcoidosis, Prog Cardiovasc Dis, 52, 336, 10.1016/j.pcad.2009.11.010 · DOI
  13. Chapelon-Abric, 2004, Cardiac sarcoidosis: a retrospective study of 41 cases, Medicine (Baltimore), 83, 315, 10.1097/01.md.0000145367.17934.75 · DOI · Paper page
  14. Fleming, 1983, Sarcoid heart disease, Br Heart J, 50, 498, 10.1136/hrt.50.5.498 · doi:10.1136/hrt.50.5.498
  15. Matsui, 1976, Clinicopathological study of fatal myocardial sarcoidosis, Ann N Y Acad Sci, 278, 455, 10.1111/j.1749-6632.1976.tb47058.x · DOI · Paper page
  16. Smedema, 2005, Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands, Chest, 128, 30, 10.1378/chest.128.1.30 · DOI
  17. Yazaki, 2001, Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone, Am J Cardiol, 88, 1006, 10.1016/S0002-9149(01)01978-6 · DOI · Paper page
  18. Uusimaa, 2008, Ventricular tachyarrhythmia as a primary presentation of sarcoidosis, Europace, 10, 760, 10.1093/europace/eun110 · DOI
  19. Iwai, 1993, Pathological studies on sarcoidosis autopsy, I: epidemiological features of 320 cases in Japan, Acta Pathol Jpn, 43, 372
  20. Iwai, 1993, Pathological studies on sarcoidosis autopsy, II: early change, mode of progression and death pattern, Acta Pathol Jpn, 43, 377
  21. Perry, 1995, Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations, Arch Pathol Lab Med, 119, 167
  22. Vignaux, 2002, Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study, J Comput Assist Tomogr, 26, 762, 10.1097/00004728-200209000-00017 · DOI
  23. Patel, 2009, Detection of myocardial damage in patients with sarcoidosis, Circulation, 120, 1969, 10.1161/CIRCULATIONAHA.109.851352 · DOI · Paper page
  24. Mehta, 2008, Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing, Chest, 133, 1426, 10.1378/chest.07-2784 · DOI · Paper page
  25. Dhôte, 2003, [Value of MRI for the diagnosis of cardiac involvement in sarcoidosis], Rev Med Interne, 24, 151, 10.1016/S0248-8663(02)00808-1 · DOI
  26. Kim, 2009, Cardiac sarcoidosis, Am Heart J, 157, 9, 10.1016/j.ahj.2008.09.009 · DOI · Paper page
  27. Sekiguchi, 1980, Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis: concepts through a study employing endomyocardial biopsy, I: sarcoidosis, Jpn Circ J, 44, 249, 10.1253/jcj.44.249 · DOI · Paper page
  28. Sadek, 2013, Corticosteroid therapy for cardiac sarcoidosis: a systematic review, Can J Cardiol, 29, 1034, 10.1016/j.cjca.2013.02.004 · DOI · Paper page
  29. Chiu, 2005, Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis, Am J Cardiol, 95, 143, 10.1016/j.amjcard.2004.08.083 · DOI · Paper page
  30. Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, JACC Cardiovasc Imaging, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
  31. Patel, 2011, Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study, Eur J Heart Fail, 13, 1231, 10.1093/eurjhf/hfr099 · DOI
  32. Judson MA. The WASOG Sarcoidosis Organ Assessment Instrument Investigators. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diff Lung Dis. In press.
  33. 2007, Diagnostic standard and guidelines for sarcoidosis, Jpn J Sarcoidosis Granulomatous Disorders, 27, 89
  34. Judson, 1999, Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 16, 75
  35. Judson, 2003, The diagnostic pathway to sarcoidosis, Chest, 123, 406, 10.1378/chest.123.2.406 · DOI · Paper page
  36. Ichinose, 2008, MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function, AJR Am J Roentgenol, 191, 862, 10.2214/AJR.07.3089 · DOI
  37. Cummings, 2009, A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging, Radiographics, 29, 89, 10.1148/rg.291085052 · DOI
  38. Pellegrino, 2005, Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG, J Nucl Med, 46, 1522
  39. Okumura, 2004, Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis, J Nucl Med, 45, 1989
  40. Langah, 2009, Effectiveness of prolonged fasting 18F-FDG PET-CT in the detection of cardiac sarcoidosis, J Nucl Cardiol, 16, 801, 10.1007/s12350-009-9110-0 · DOI · Paper page
  41. Ishimaru, 2005, Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis, Eur Heart J, 26, 1538, 10.1093/eurheartj/ehi180 · DOI · Paper page
  42. Ardehali, 2005, A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy, Am Heart J, 150, 459, 10.1016/j.ahj.2004.10.006 · DOI
  43. Nery, 2012, Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy, Can J Cardiol
  44. Kandolin, 2011, Diagnosing isolated cardiac sarcoidosis, J Intern Med, 10.1111/j.1365-2796.2011.02396.x · DOI · Paper page
  45. Leone, 2012, 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology, Cardiovasc pathol, 21, 245, 10.1016/j.carpath.2011.10.001 · DOI · Paper page
  46. Freeman, 2013, Predictors of cardiac sarcoidosis using commonly available cardiac studies, Am J Cardiol, 112, 280, 10.1016/j.amjcard.2013.03.027 · DOI
  47. Schuller, 2011, Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis, Ann Noninvasive Electrocardiol, 16, 70, 10.1111/j.1542-474X.2010.00411.x · DOI
  48. Schuller, 2011, Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement, J Cardiovasc Electrophysiol, 22, 1243, 10.1111/j.1540-8167.2011.02099.x · DOI
  49. Kandolin, 2011, Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults, Circ Arrhythm Electrophysiol, 4, 303, 10.1161/CIRCEP.110.959254 · DOI · Paper page
  50. Nery PB, Beanlands RS, Nair G, et al. Middle aged patients with new onset atrioventricular block should be investigated for cardiac sarcoidosis. Heart Rhythm 2013 January 5;10:S447.
  51. Nery, 2013, Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia, Pacing Clin Electrophysiol
  52. Koplan, 2006, Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation, Heart Rhythm, 3, 924, 10.1016/j.hrthm.2006.03.031 · DOI
  53. Santucci, 2004, Electroanatomic mapping of the right ventricle in a patient with a giant epsilon wave, ventricular tachycardia, and cardiac sarcoidosis, J Cardiovasc Electrophysiol, 15, 1091, 10.1046/j.1540-8167.2004.03708.x · doi:10.1046/j.1540-8167.2004.03708.x
  54. Vasaiwala, 2009, Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia, J Cardiovasc Electrophysiol, 20, 473, 10.1111/j.1540-8167.2008.01351.x · DOI
  55. Dechering, 2013, Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy, Heart Rhythm, 10, 158, 10.1016/j.hrthm.2012.10.019 · DOI
  56. Steckman, 2012, Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy, Am J Cardiol, 110, 575, 10.1016/j.amjcard.2012.04.029 · DOI
  57. Epstein, 2008, ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary, Heart Rhythm, 5, 934, 10.1016/j.hrthm.2008.04.015 · DOI · Paper page
  58. Epstein, 2013, Circulation, 127, e283, 10.1161/CIR.0b013e318276ce9b · DOI · Paper page
  59. Erdmann, 1980, [Angina pectoris, pathological stress EKG and a normal coronary angiogram], Internist (Berl), 21, 165
  60. Okamoto, 1999, Cutaneous sarcoidosis with cardiac involvement, Eur J Dermatol, 9, 466
  61. Kato, 2003, Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block, Sarcoidosis Vasc Diffuse Lung Dis, 20, 133
  62. Banba, 2007, Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis, Heart Rhythm, 4, 1292, 10.1016/j.hrthm.2007.06.006 · DOI · Paper page
  63. Yodogawa, 2011, Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis, Ann Noninvasive Electrocardiol, 16, 140, 10.1111/j.1542-474X.2011.00418.x · DOI
  64. Wann, 2011, 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 57, 223, 10.1016/j.jacc.2010.10.001 · DOI
  65. Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association, Europace, 14, 1385, 10.1093/europace/eus305 · DOI · Paper page
  66. Golwala, 2011, Atrial fibrillation as the initial clinical manifestation of cardiac sarcoidosis: a case report and review of the literature, J Cardiovasc Med (Hagerstown ), 10.2459/JCM.0b013e328343b589 · DOI
  67. Viles-Gonzalez, 2013, Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications, Chest, 143, 1085, 10.1378/chest.11-3214 · DOI
  68. Zipse, 2013, Atrial arrhythmias are common and arise from diverse mechanisms in patients with cardiac sarcoidosis, Heart Rhythm, 10, S309
  69. Schuller, 2012, Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis, J Cardiovasc Electrophysiol, 23, 925, 10.1111/j.1540-8167.2012.02350.x · DOI
  70. Betensky, 2012, Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators, Heart Rhythm, 9, 884, 10.1016/j.hrthm.2012.02.010 · DOI
  71. Kron, 2013, Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis, Europace, 15, 347, 10.1093/europace/eus316 · DOI · Paper page
  72. Namboodiri, 2012, Electrophysiological features of atrial flutter in cardiac sarcoidosis: a report of two cases, Indian Pacing Electrophysiol J, 12, 284, 10.1016/S0972-6292(16)30568-X · DOI
  73. Srivatsa, 2012, Sarcoidosis and atrial fibrillation: a rare association and interlink with inflammation, Indian Pacing Electrophysiol J, 12, 290, 10.1016/S0972-6292(16)30569-1 · doi:10.1016/s0972-6292(16)30569-1
  74. Swigris, 2011, Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007, Chest, 140, 1261, 10.1378/chest.11-0324 · DOI
  75. Echt, 1991, Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial, N Engl J Med, 324, 781, 10.1056/NEJM199103213241201 · DOI · Paper page
  76. Jefic, 2009, Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry, Heart Rhythm, 6, 189, 10.1016/j.hrthm.2008.10.039 · DOI · Paper page
  77. Berte, 2008, Bidirectional ventricular tachycardia in fulminant myocarditis, Europace, 10, 767, 10.1093/europace/eun105 · DOI
  78. Tai, 1992, Incessant automatic ventricular tachycardia complicating acute coxsackie B myocarditis, Cardiology, 80, 339, 10.1159/000175023 · DOI
  79. Stees, 2010, Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis, J Cardiovasc Electrophysiol, 10.1111/j.1540-8167.2010.01826.x · DOI
  80. Tselentakis, 2006, Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation, J Surg Res, 135, 68, 10.1016/j.jss.2006.03.024 · DOI
  81. Futamatsu, 2006, Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia, Int J Cardiovasc Imaging, 22, 443, 10.1007/s10554-005-9043-x · DOI
  82. Winters, 1991, Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device, J Am Coll Cardiol, 18, 937, 10.1016/0735-1097(91)90750-4 · DOI · Paper page
  83. Furushima, 2004, Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome, Clin Cardiol, 27, 217, 10.1002/clc.4960270409 · DOI
  84. Hiramitsu, 2005, National survey on status of steroid therapy for cardiac sarcoidosis in Japan, Sarcoidosis Vasc Diffuse Lung Dis, 22, 210
  85. Bogun, 2009, Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate, J Am Coll Cardiol, 53, 1138, 10.1016/j.jacc.2008.11.052 · DOI
  86. Kuhne, 2010, Isolated potentials and pace-mapping as guides for ablation of ventricular tachycardia in various types of nonischemic cardiomyopathy, J Cardiovasc Electrophysiol, 21, 1017, 10.1111/j.1540-8167.2010.01756.x · doi:10.1111/j.1540-8167.2010.01756.x
  87. Mehta, 2011, Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation, Circ Arrhythm Electrophysiol, 4, 43, 10.1161/CIRCEP.110.958322 · DOI
  88. Aizer, 2005, Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis, Am J Cardiol, 96, 276, 10.1016/j.amjcard.2005.03.059 · DOI
  89. Kramer, 2013, Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update, J Cardiovasc Magn Reson, 15, 91, 10.1186/1532-429X-15-91 · DOI · Paper page
  90. Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2013;October 1. · doi:10.1016/s0735-1097(12)61311-4
  91. Mc Ardle, 2013, Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-fluorodeoxyglucose positron emission tomography?, Circ Cardiovasc Imaging, 6, 617, 10.1161/CIRCIMAGING.112.000289 · DOI
  92. Schuller, 2009, Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis, J Interv Card Electrophysiol
  93. Hamzeh, 2012, Management of cardiac sarcoidosis in the United States: a Delphi study, Chest, 141, 154, 10.1378/chest.11-0263 · DOI
  94. Osborne, 2013, Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis, J Nucl Cardiol

Cited by

See all 1,479

Metadata

Authors
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., Patel, A. R., Ohe, T., Raatikainen, P., & Soejima, K.
Venue
Heart Rhythm
Publisher
Elsevier BV
Published
2014-07
Volume
11
Issue
7
Pages
1304-1323
ISSN
1547-5271 (ISSN-L)
DOI
10.1016/j.hrthm.2014.03.043
OpenAlex
W2010909136
Cited by
1,479
References
4
FWCI
54.62
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis. https://app.cochat.ai/papers/10.1016/j.hrthm.2014.03.043
The paper
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., Patel, A. R., Ohe, T., Raatikainen, P., & Soejima, K. (2014). HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2014.03.043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.